Asthma is a complex inflammatory disorder in which interleukin (IL)-13 acting through STAT6 has been identified as a major driver of bronchial inflammation [1–3], prompting efforts to therapeutically target this pathway [4–6]. The gene discussed is STAT6; the disease is asthma.